Sotera Health 2026: Revenue $324.89M, Net income $58.39M, EPS $0.2— 10-Q Summary

What happened

Sotera Health reported revenue of $324.89 million for 2026, up 4.4% from the prior-year period, and net income of $58.39 million, up 20.6%. Diluted earnings per share, or profit allocated to each share, rose to $0.20 from $0.17.

Confirmed

Global impact / market context

Revenue growth alongside faster net income growth indicates the company converted more sales into profit in this period. However, the reported nine-month segment figures were mixed, and higher capital spending on facilities, expansion, and Co-60 needs can use cash before those investments generate returns.

Analyst inference

The summary reports nine-month revenue growth across the business and its named segments, but also a revenue decline at Nordion in the third quarter and lower Nelson Labs segment income. This points to differing service demand, timing, pricing, volume, and cost pressures.

Analyst inference

What to watch

1. Watch whether revenue growth continues and whether net income keeps rising faster than sales; that would indicate the company is retaining more profit from its business. Analyst inference
2. Track capital spending and facility expansion, including Co-60 needs, against cash generation; spending that rises faster than cash available could limit financial flexibility. Analyst inference
3. Check later disclosures for Nordion’s quarterly revenue and Nelson Labs’ segment income, to see whether the reported timing, mix, and inflation pressures persist or ease. Analyst inference

Evidence

• Original source link unavailable